Chemoradiotherapy With Surgery Followed by Consolidation Durvalumab

Patients with initially unresectable stage III NSCLC will undergo surgery after chemoradiotherapy completion when the tumor is deemed resectable by the thoracic oncology tumor board and will then receive durvalumab